Diagnosis and treatment of feline systemic hypertension

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 19, Issue 2, 1997, Pages 163-178

  Henik, Rosemary A ^a,b,c  

^a UNIVERSITY OF WISCONSIN   (United States)

^b AMER COLL OF VET INT MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; FELIDAE; FELIS CATUS;

EID: 5244336181     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Berne RM, Levy MN: Cardiovascular Physiology, ed 6. Chicago, Mosby Year Book, 1992, pp 135-151.
2. Dustan HP: Pathophysiology of systemic hypertension, in Hurst JW (ed): The Heart. St. Louis, McGraw-Hill Information Services Co, 1990, pp 1140-1150.
3. Waeber B, Brunner HR, Burnier M, et al: Hypertension, in Willerson JT, Cohn JN (eds): Cardiovascular Medicine. New York, Churchill Livingstone, 1995, pp 1228-1263.
4. Wessale JL, Smith LA, Reid M, et al: Indirect auscultatory systolic and diastolic pressures in the anesthetized dog. Am J Vet Res 46:2129-2132, 1985.
5. Binns SH, Sisson DD, Buoscio DA, et al: Doppler ultrasonographic, oscillometric sphygmomanometric, and photoplethysmographic techniques for noninvasive blood pressure measurement in anesthetized cats. J Vet Intern Med 9:405-414, 1995.
6. Kazamias TM, Gander MP, Franklin DL, et al: Blood pressure measurement with the Doppler ultrasonic flowmeter. J Appl Physiol 30:585-588, 1971.
7. Coulter D, Keith J: Blood pressures obtained by indirect measurement in conscious dogs. JAVMA 184:1375-1378, 1984.
8. Hassler CR, Lutz GA, Linebaugh R, et al: Identification and evaluation of noninvasive blood pressure measuring techniques. Toxicol Appl Pharmacol 47:193-201, 1979.
9. Valtonen MH, Eriksson LM: The effect of cuff width on accuracy of indirect measurement of blood pressure in dogs. Res Vet Sci 11:358-362, 1970.
10. Grandy JL, Dunlop CI, Hodgson DS, et al: Evaluation of the Doppler ultrasonic method of measuring systolic arterial blood pressure in cats. Am J Vet Res 53:1166-1169, 1992.
11. Snyder PS, Henik RA: Feline systemic hypertension. Proc 12th Annu Vet Med Forum: 126-128, 1994.
12. Meldrum SJ: The principles underlying Dinamap, a microprocessor-based instrument for the automatic determination of mean arterial pressure. J Med Eng Technol 2:243-244, 1978.
13. Yamakoshi K, Rolfe P, Murphy C: Current developments in non-invasive measurement of arterial blood pressure. J Biomed Eng 10:130-136, 1988.
14. Stokes DN, Clutton-Brock T, Patil C, et al: Comparison of invasive and non-invasive measurement of continuous arterial pressure using the Finapres. Br J Anesth 67:26-35, 1991.
15. Tabaru H, Watanabe H, Tanaka M, et al: Non-invasive measurement of systemic arterial pressure by Finapres in anesthetized dogs. Jpn J Vet Sci 52:427-430, 1990.
16. Littman MP: Chronic spontaneous systemic hypertension in dogs and cats. Proc 8th ACVIM Forum:209-212, 1990.
17. Edwards NJ: Non-invasive blood pressure measurements in the clinical setting. Proc 8th ACVIM Forum:273-275, 1990.
18. Kobayashi DL, Peterson ME, Graves TK, et al: Hypertension in cats with chronic renal failure or hyperthyroidism. J Vet Intern Med 4:58-62, 1990.
19. Lesser M, Fox PR, Bond BR: Assessment of hypertension in 40 cats with left ventricular hypertrophy by Doppler-shift sphygmomanometry. J Small Anim Pract 33:55-58, 1992.
20. Labato MA, Ross LA: Diagnosis and management of hypertension, in August JR (ed): Consultations in Feline Internal Medicine. Philadelphia, WB Saunders Co, 1991, pp 301-308.
21. Littman MP: Spontaneous systemic hypertension in 24 cats. J Vet Intern Med 8:79-86, 1994.
22. Stiles J, Polzin DJ, Bistner SI: The prevalence of retinopathy in cats with systemic hypertension and chronic renal failure or hyperthyroidism. JAAHA 30:564-572, 1994.
23. Morgan RV: Systemic hypertension in four cats: Ocular and medical findings. JAAHA 22:615-621, 1986.
24. Acosta J: Hypertension in chronic renal disease. Kidney Int 22:702-712, 1982.
25. Mitas J, O'Connor D: Hypertension in renal insufficiency. Postgrad Med 6:113-120, 1978.
26. Henik RA, Jensen J, Brownfield M, et al: Plasma renin activity, angiotensin I, and aldosterone concentrations in normal and hypertensive cats. Proc BSAVA Annu Cong:228, 1996.
27. Turner JL, Brogdon JD, Lees GE, et al: Idiopathic hypertension in a cat with secondary hypertensive retinopathy associated with a high-salt diet. JAAHA 26:647-651, 1990.
28. Bonagura JD: Cardiovascular diseases, in Sherding RG (ed): The Cat: Diseases and Clinical Management. New York, Churchill Livingstone, 1994, pp 819-946.
29. Dukes J: Hypertension: A review of the mechanisms, manifestations and management. J Small Anim Prac 33:119-129, 1992.
30. Vuille C, Weyman AE: Left ventricle. I. General considerations, assessment of chamber size and function, in Weyman AE (ed): Principles and Practice of Echocardiography. Philadelphia, Lea & Febiger, 1994, pp 575-624.
31. Kanatsu H, Lamping KG, Eastham CL, et al: Coronary microvascular resistance in hypertensive cats. Circ Res 68:726-733, 1991.
32. DiBartola SP, Rutgers HC, Zack PM, et al: Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984). JAVMA 190:1196-1202, 1987.
33. Dow SW, Fettman MJ, LeCouteur RA, et al: Potassium depletion in cats: Renal and dietary influences. JAVMA 191:1569-1575, 1987.
34. Dow SW, Fettman MJ, Curtis CR, et al: Hypokalemia in cats: 186 cases (1984-1987). JAVMA 194:1604-1608, 1989.
35. Henik RA, Snyder PS, Volk LM: Amlodipine besylate therapy in cats with systemic arterial hypertension secondary to chronic renal disease. Proc 12th ACVIM Forum:976, 1994.
36. Maclean D, Mitchell ET, Wilcox RG, et al: Amlodipine and captopril in moderate-severe essential hypertension. J Hum Hypertens 2:127-132, 1988.
37. Dodd MG, Gardiner DG, Carter AJ, et al: The hemodynamic properties of amlodipine in anesthetized and conscious dogs: Comparison with nitrendipine and influence of beta-adrenergic blockade. Cardiovasc Drug Ther 3:545-555, 1989.
38. Ad Hoc Committee for the National Kidney Foundation: Statement of the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Am J Kidney Dis 14: 163-169, 1989.